Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate Endpoints
NCT00292552
·
clinicaltrials.gov ↗
COMPLETED
Status
2747
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
OTHER:
Novel endpoint determination
Sponsor
GlaxoSmithKline